- 1、本文档共65页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 非渗透性物质 维持保护液有效的渗透压,预防或降低细胞水肿 主要包括:葡萄糖、蔗糖、甘露醇、棉子糖、组氨酸、乳糖、軥橼酸盐等 非渗透物质的分子大小与其有效性相关,分子量越大,其抗细胞水肿的效应越强 保护液中的非渗透性成分 Collins EC UW PBS HTK HOC Celsior Glu 25 195 - - - - - Histidine - - - - 198 - 30 Lactobionate - - 100 - - - 80 Mannitol - - - - 30 185 60 Raffinose - - 30 - - - - Sucrose - - - 140 - - - TEE 移植前的心功能再评价 移植后心内气泡的监测 移植后心功能评估、有无局部室壁运动异常、各瓣膜情况等 移植后心脏的各吻合口区的血流速度 评价肺动脉漂浮导管的位置 谢 谢 * * * * * * * * * Center volume compared with ISHLT,本中心已经达到国际领先水平。 * 本中心心脏移植患者首要原发心脏病因为心肌病75%,比例高于国际报告。其次为冠心病占17%,比例低于国际报告。 * * 本中心与国际对比,年龄较轻。18-34岁和35-49岁年龄段比例较大。60岁以上比例低于国际报告。 * * * * * Survival was calculated using the Kaplan-Meier method, which incorporates information from all transplants for whom any follow-up has been provided. Since many patients are still alive and some patients have been lost to follow-up, the survival rates are estimates rather than exact rates because the time of death is not known for all patients. The half-life is the estimated time point at which 50% of all of the recipients have died. Survival rates were compared using the log-rank test statistic. No adjustments were made for multiple comparisons. * Survival was calculated using the Kaplan-Meier method, which incorporates information from all transplants for whom any follow-up has been provided. Since many patients are still alive and some patients have been lost to follow-up, the survival rates are estimates rather than exact rates because the time of death is not known for all patients. The half-life is the estimated time point at which 50% of all of the recipients have died. Survival rates were compared using the log-rank test statistic. No adjustments were made for multiple comparisons. * Survival was calculated using the Kaplan-Meier method, which incorporates information from all transplants for whom any follow-up has been provided. Since many patients are still alive and some patients have been lost to follow-up, th
文档评论(0)